ConSynance Therapeutics is a clinical-stage biopharmaceutical company targeting rare central nervous system diseases.  We aim to turn breakthrough science into transformative therapies for patients, with our focus on Prader-Willi Syndrome, hypothalamic injury-induced obesity, and narcolepsy with cataplexy.

Phone Number

+1 (518) 275-0176

Email Address


Health Sciences Campus

11 University Place

Rensselaer, NY 12144

Consynance Logo.png

Sign Up for ConSynance Updates

Get our news and updates on our progress and upcoming events.

© ConSynance Therapeutics | All Rights Reserved 2019